4 Results for "

wild-type B-Raf kinase

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "wild-type B-Raf kinase" in MCE Product Catalog:

Cat. No.: HY-77113
CAS No.: 918504-27-5
Target:  

Raf

Research Areas:  

Cancer

B-Raf IN 11 is a B-Raf V600E mutant kinase inhibitor with an IC50 of 76 nM, and exhibits an IC50 of 238 nM against wild-type B-Raf kinase. B-Raf IN 11 inhibits the kinase activities of B-Raf V600E mutant and wild-type B-Raf kinase. B-Raf IN 11 is applicable to relevant research on colorectal cancer .
loading...
    loading...
Cat. No.: HY-117273
CAS No.: 942507-42-8
Purity:  99.77%
Target:  

Raf Autophagy

Research Areas:  

Cancer

AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity .
loading...
    loading...
Cat. No.: HY-P10436
CAS No.: 2411851-64-2
Target:  

Raf

Research Areas:  

Cancer

Braftide is an allosteric inhibitor for BRAF kinase by targeting the dimer interface of BRAF kinase and inhibiting the formation of BRAF dimers. Braftide inhibits wild-type BRAF and oncogenic BRAF G469A with IC50 of 364 nM and 172 nM, respectively. Braftide inhibits MAPK signaling pathway, inhibits proliferation of KRAS mutant tumor cells (EC50 is 7.1 and 6.6 μM, for HCT116 and HCT-15), in combination of TAT sequence. Braftide can be used for cancer research .
loading...
    loading...
Cat. No.: HY-137488
CAS No.: 2417296-82-1
Target:  

PROTACs Raf

Research Areas:  

Cancer

PROTAC BRAF-V600E degrader-2 (compound 12) is a potent BRAF-V600E degrader with Kds of 14.4 nM and 9.5 nM for BRAF and BRAF-V600E, respectively. PROTAC BRAF-V600E degrader-2 selectively degraded the kinase domain of BRAF-V600E but not the wild-type BRAF. PROTAC BRAF-V600E degrader-2 inhibits melanoma cell growth .
loading...
    loading...